IT1271267B - Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi - Google Patents
Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidiInfo
- Publication number
- IT1271267B IT1271267B ITMI942513A ITMI942513A IT1271267B IT 1271267 B IT1271267 B IT 1271267B IT MI942513 A ITMI942513 A IT MI942513A IT MI942513 A ITMI942513 A IT MI942513A IT 1271267 B IT1271267 B IT 1271267B
- Authority
- IT
- Italy
- Prior art keywords
- search
- compounds
- cannabinoids
- mono
- acid amides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/49—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI942513A IT1271267B (it) | 1994-12-14 | 1994-12-14 | Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi |
PCT/EP1995/004926 WO1996018600A1 (en) | 1994-12-14 | 1995-12-13 | Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
CA002207804A CA2207804C (en) | 1994-12-14 | 1995-12-13 | Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
EP95942141A EP0799188B1 (en) | 1994-12-14 | 1995-12-13 | Amides of mono and dicarboxylic acids with glycosamines, selectively active on the cannabinoid peripheral receptor |
JP51826496A JP4111349B2 (ja) | 1994-12-14 | 1995-12-13 | カンナビノイド末梢レセプターに選択的に作用するモノおよびビカルボン酸のアミノ酸あるいはグリコサミンとのアミド類 |
DE69512273T DE69512273T2 (de) | 1994-12-14 | 1995-12-13 | Amide von mono-und dicarbonsäuren mit glycosaminen, mit selektiver wirkung auf den peripheren cannabinoiden rezeptor |
AU43441/96A AU4344196A (en) | 1994-12-14 | 1995-12-13 | Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
AT95942141T ATE184591T1 (de) | 1994-12-14 | 1995-12-13 | Amide von mono-und dicarbonsäuren mit glycosaminen, mit selektiver wirkung auf den peripheren cannabinoiden rezeptor |
IL11640195A IL116401A0 (en) | 1994-12-14 | 1995-12-14 | Amid s of ono a d dic rboxy ic acids with aminoalcohols selectively active on the cannabinoid peripheral receptor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI942513A IT1271267B (it) | 1994-12-14 | 1994-12-14 | Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI942513A0 ITMI942513A0 (it) | 1994-12-14 |
ITMI942513A1 ITMI942513A1 (it) | 1996-06-14 |
IT1271267B true IT1271267B (it) | 1997-05-27 |
Family
ID=11369990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI942513A IT1271267B (it) | 1994-12-14 | 1994-12-14 | Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0799188B1 (it) |
JP (1) | JP4111349B2 (it) |
AT (1) | ATE184591T1 (it) |
AU (1) | AU4344196A (it) |
CA (1) | CA2207804C (it) |
DE (1) | DE69512273T2 (it) |
IL (1) | IL116401A0 (it) |
IT (1) | IT1271267B (it) |
WO (1) | WO1996018600A1 (it) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19706903A1 (de) | 1997-02-21 | 1998-08-27 | Bayer Ag | Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1 |
EP1071419B1 (en) | 1998-04-21 | 2007-07-25 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Cannabinoids as antioxidants and neuroprotectants |
DE60042004D1 (de) | 1999-04-28 | 2009-05-28 | Toray Industries | Stoffe zur enternung von cannabinoiden und säulen mit diesen stoffen zur entfernung von cannabinoiden |
ES2368199T3 (es) | 1999-07-07 | 2011-11-15 | Innovet Italia S.R.L. | Derivados covalentes de alcanolamidas de ácidos monocarboxílicos y dicarboxílicos funcionalmente activos en el receptor cannabinoide cb2. |
WO2002029001A2 (en) * | 2000-10-03 | 2002-04-11 | University Of Virginian Patent Foundation | Novel lysophosphatidic acid receptor agonists and antagonists |
US8449908B2 (en) | 2000-12-22 | 2013-05-28 | Alltranz, Llc | Transdermal delivery of cannabidiol |
WO2002064616A2 (en) | 2001-01-30 | 2002-08-22 | University Of Virgina Patent Foundation | Agonists and antagonists of sphingosine-1-phosphate receptors |
ITMI20011483A1 (it) * | 2001-07-11 | 2003-01-11 | Res & Innovation Soc Coop A R | Uso di composti come antagonisti funzionali ai recettori centrali deicannabinoidi |
US20050101590A1 (en) | 2002-02-19 | 2005-05-12 | Kiyoshi Yasui | Antipruritics |
AU2003217961B2 (en) | 2002-03-08 | 2008-02-28 | Signal Pharmaceuticals, Llc | Combination therapy for treating, preventing or managing proliferative disorders and cancers |
ES2284807T3 (es) * | 2002-06-26 | 2007-11-16 | Innovet Italia S.R.L. | Composicion farmaceutica para prevenir el desarrollo y la progresion de enfermedades cutaneas superficiales. |
EP1917956A3 (en) * | 2002-07-25 | 2008-12-31 | Lion Corporation | External preparation composition |
WO2004082673A1 (ja) * | 2003-03-20 | 2004-09-30 | Menicon Co. Ltd. | 眼科用液剤組成物 |
EP1750722A4 (en) | 2004-05-06 | 2010-03-10 | Univ Virginia | NEW LYSOPHOSPHIC ACID RECEPTORSELECTIVE ANTAGONISTS |
ITMI20041567A1 (it) * | 2004-07-30 | 2004-10-30 | Maycos Italiana Di Comini Miro | "derivati n-acilati di acidi bicarbossilici con amminoacidi e con idrolizzati proteici vegetali e loro applicazione in prodotti cosmetici, dermofarmaceutici e farmaceutici" |
EP2176208B1 (en) | 2007-07-30 | 2015-01-21 | Zynerba Pharmaceuticals, Inc. | Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
WO2009125409A2 (en) * | 2008-04-09 | 2009-10-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Fatty acid amides and uses thereof |
MY144409A (en) * | 2009-04-09 | 2011-09-15 | Malaysian Palm Oil Board | A method of producing derivatives of azelaic acid |
AU2012210179C1 (en) * | 2011-01-24 | 2016-11-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Nanoparticles based for dermal and systemic delivery of drugs |
CN106232577B (zh) | 2014-04-25 | 2019-02-22 | 味之素株式会社 | 免疫刺激剂 |
EP3368508A1 (en) | 2015-10-28 | 2018-09-05 | Ajinomoto Co., Inc. | Immunostimulating agent |
IT201800000728A1 (it) * | 2018-01-11 | 2019-07-11 | Univ Degli Studi Di Milano Bicocca | Nuovi antagonisti del tlr4 umano |
IT201800003912A1 (it) * | 2018-03-26 | 2019-09-26 | Innovet Italia Srl | N-palmitoil-d-glucosamina in forma micronizzata |
EP3574899A1 (en) * | 2018-05-28 | 2019-12-04 | Université de Bourgogne | Oleic acid derivatives, pharmaceutical composition or food composition comprising said oleic acid derivatives, and their uses |
CN112341354B (zh) * | 2020-09-24 | 2022-06-10 | 湖北泓肽生物科技有限公司 | 一种pms的合成方法 |
CN113502153B (zh) * | 2021-07-07 | 2023-02-14 | 哈尔滨工程大学 | 一种非芳香性发光小分子/SiO2杂化的荧光纳米材料及其制备方法与应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5117535B2 (it) * | 1973-04-23 | 1976-06-03 | ||
JPS5117534B2 (it) * | 1973-04-23 | 1976-06-03 | ||
JPS5850961B2 (ja) * | 1976-11-05 | 1983-11-14 | カネボウ株式会社 | 安定化された毛髪染色用組成物 |
US4933363A (en) * | 1988-08-16 | 1990-06-12 | Elsohly Mahmoud A | Method for effecting systemic delivery of delta-9-tetrahydrocannabinol |
US4999417A (en) * | 1989-03-30 | 1991-03-12 | Nova Pharmaceutical Corporation | Biodegradable polymer compositions |
JP3202777B2 (ja) * | 1992-01-24 | 2001-08-27 | リンテック株式会社 | 経皮吸収促進剤及びテープ製剤 |
IL101708A (en) * | 1992-04-28 | 1996-08-04 | Senyorina Ltd | Anti-fattening drugs comprising amino acid derivatives |
JP3435195B2 (ja) * | 1992-10-30 | 2003-08-11 | 花王株式会社 | 皮脂分泌抑制剤 |
IL103932A (en) * | 1992-11-30 | 1997-02-18 | Yissum Res & Dev | Fatty acid and pharmaceutical compositions containing them |
-
1994
- 1994-12-14 IT ITMI942513A patent/IT1271267B/it active IP Right Grant
-
1995
- 1995-12-13 AU AU43441/96A patent/AU4344196A/en not_active Abandoned
- 1995-12-13 CA CA002207804A patent/CA2207804C/en not_active Expired - Lifetime
- 1995-12-13 WO PCT/EP1995/004926 patent/WO1996018600A1/en active IP Right Grant
- 1995-12-13 EP EP95942141A patent/EP0799188B1/en not_active Expired - Lifetime
- 1995-12-13 DE DE69512273T patent/DE69512273T2/de not_active Expired - Lifetime
- 1995-12-13 AT AT95942141T patent/ATE184591T1/de active
- 1995-12-13 JP JP51826496A patent/JP4111349B2/ja not_active Expired - Lifetime
- 1995-12-14 IL IL11640195A patent/IL116401A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0799188A2 (en) | 1997-10-08 |
JPH11501615A (ja) | 1999-02-09 |
ATE184591T1 (de) | 1999-10-15 |
ITMI942513A0 (it) | 1994-12-14 |
ITMI942513A1 (it) | 1996-06-14 |
EP0799188B1 (en) | 1999-09-15 |
CA2207804C (en) | 2007-08-07 |
IL116401A0 (en) | 1996-03-31 |
DE69512273T2 (de) | 2000-05-11 |
DE69512273D1 (de) | 1999-10-21 |
AU4344196A (en) | 1996-07-03 |
WO1996018600A1 (en) | 1996-06-20 |
JP4111349B2 (ja) | 2008-07-02 |
CA2207804A1 (en) | 1996-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1271267B (it) | Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi | |
CA2200707A1 (en) | Novel prostaglandin synthase inhibitors | |
CA2304713A1 (en) | Biphenyl-5-alkanoic acid derivatives and use thereof | |
KR970704864A (ko) | 세정제 조성물 | |
EA200200510A1 (ru) | 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр | |
RU94033486A (ru) | Способ получения 3-арил-бензофуранонов | |
HK1075660A1 (en) | Polycyclic compounds as potent alpha2-adrenoceptorantagonists | |
AU6570186A (en) | Novel pyrrolidinylamide ester derivative having anti-prolyl endopeptidase activity and synthesis and use thereof | |
CA2133885A1 (en) | Crystalline inclusion complex of diclofenac with beta-cyclodextrin | |
DE59902779D1 (de) | Kristallmodifikation der liponsäure | |
ID30511A (id) | Proses polimerisasi radikal bebas dengan penghentian segera | |
FI955498A0 (fi) | Nipekotiinihappojohdannaisia hyytymistä estävinä aineina | |
KR950008497A (ko) | 락톨 유도체, 이의 제법 및 용도 | |
FR2854629B1 (fr) | Procede de synthese de la 4-hydroxyisoleucine et de ses derives | |
MX9603348A (es) | Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa. | |
EA200101001A1 (ru) | Декурсинол или его производное в качестве аналгезирующего средства | |
ES2128031T3 (es) | Forma cristalina y polimorfica de (s,s,s)-n-(1-(2-carboxi-3-(n2-mesilisilamino)propil)-1-ciclopentilcarbonil)tirosina. | |
AU563426B2 (en) | 3-alkoxy-2(n-pyrrolidino)-n-pyridyl-n-furyl (or thienyl) methyl propylamines | |
BR0013094A (pt) | Processo para a preparação de compostos 1,3-dicarbonìlicos acilados | |
CA2183320A1 (en) | Novel Mercaptoacetylamide Disulfide Derivatives Useful as Inhibitors of Enkephalinase and Ace | |
BR9405186A (pt) | Processo para a preparação de 2,4,5-tribromopirrol-3-carbonitrila | |
ATE93260T1 (de) | Fluessigkristallzusammensetzung und vorrichtung, die diese verwendet. | |
FI960588A0 (fi) | Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä | |
CA2276320A1 (en) | L-tartrate of trans-(-)-4-(4-fluorophenyl)-3-hydroxymethylpiperidine compound and process for preparing the same | |
KR960037049A (ko) | 케노데옥시콜린산의 유도체를 함유하는 혈관형성 억제제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |